Intracel Report issue

For profit Phase 2 Phase 3
Founded: Frederick MD United States (1985)
Status: Defunct (2002)

Organization Overview

First Clinical Trial
1998
NCT00006034
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2001

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colonic Neoplasms (Phase 2)

Urinary Bladder Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 6